Production and prevention of fatty liver in rats fed clofibrate and orotic acid diets containing sucrose.
D000818:Animals; D001059:Apoproteins / Q000032:analysis; D002784:Cholesterol / Q000032:analysis; D002994:Clofibrate / Q000008:administration & dosage* / Q000627:therapeutic use; D004032:Diet; D004357:Drug Synergism; D004721:Endoplasmic Reticulum / Q000187:drug effects / Q000378:metabolism; D005234:Fatty Liver / Q000139:chemically induced* / Q000517:prevention & control; D006041:Goats / Q000276:immunology; D006056:Golgi Apparatus / Q000187:drug effects / Q000378:metabolism; D007122:Immunoelectrophoresis; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism / Q000473:pathology; D008297:Male; D008928:Mitochondria / Q000187:drug effects; D009963:Orotic Acid / Q000008:administration & dosage* / Q000627:therapeutic use; D051381:Rats; D013395:Sucrose / Q000627:therapeutic use; D014280:Triglycerides / Q000032:analysis / Q000097:blood
D001059:Apoproteins; D014280:Triglycerides; D013395:Sucrose; D009963:Orotic Acid; D002784:Cholesterol; D002994:Clofibrate